STOCK TITAN

Omega Therapeutics to Participate in The Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
OMGA: Omega Therapeutics to Participate in Fireside Chat at Jefferies London Healthcare Conference on November 14, 2023
Positive
  • Omega Therapeutics, Inc. will be participating in a fireside chat at the Jefferies London Healthcare Conference, showcasing the company's innovative approach to developing programmable epigenomic mRNA medicines.
Negative
  • None.

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023, at 12:30 p.m. GMT (7:30 a.m. ET).

A live webcast of the fireside chat will be available on the Investors & Media section of the Company's website at www.omegatherapeutics.com. An archived replay of the fireside chat will be available on the same website for approximately 90 days.

About Omega Therapeutics
Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines to treat or cure a broad range of diseases. By pre-transcriptionally modulating gene expression, Omega’s approach enables controlled epigenomic modulation of nearly all human genes, including historically undruggable and difficult-to-treat targets, without altering native nucleic acid sequences. Founded in 2017 by Flagship Pioneering following breakthrough research by world-renowned experts in the field of epigenetics, Omega is led by a seasoned and accomplished leadership team with a track record of innovation and operational excellence. The Company is committed to revolutionizing genomic medicine and has a diverse pipeline of therapeutic candidates derived from its OMEGA platform spanning oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

For more information, visit omegatherapeutics.com, or follow us on X (formerly Twitter) and LinkedIn.



FAQ

What is the event Omega Therapeutics, Inc. will be participating in on November 14, 2023?

Omega Therapeutics, Inc. will be participating in a fireside chat at the Jefferies London Healthcare Conference on November 14, 2023.

Where can I watch the live webcast of the fireside chat?

The live webcast of the fireside chat will be available on the Investors & Media section of Omega Therapeutics, Inc.'s website at www.omegatherapeutics.com.

How long will the archived replay of the fireside chat be available?

An archived replay of the fireside chat will be available on Omega Therapeutics, Inc.'s website for approximately 90 days.

Omega Therapeutics, Inc.

NASDAQ:OMGA

OMGA Rankings

OMGA Latest News

OMGA Stock Data

152.23M
21.36M
1.97%
94.48%
7.32%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE

About OMGA

omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for a range of disease indications including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology. # transformativemedicines #pioneeringmedicines